查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1904573

伴侣动物基因体学和DNA检测市场预测至2032年：按检测类型、动物类型、通路、技术、应用、最终用户和地区分類的全球分析

Companion Animal Genomics & DNA Testing Market Forecasts to 2032 - Global Analysis By Test Type, Animal Type, Distribution Channel, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的一项研究，全球伴侣动物基因组学和 DNA 检测市场预计在 2025 年达到 8.6455 亿美元，预计到 2032 年将达到 15.1075 亿美元，在预测期内的复合年增长率为 8.3%。

伴侣动物基因组学和DNA检测是指对宠物（例如犬猫）的遗传物质进行科学分析，以了解其品种组成、遗传特征、健康风险和祖先资讯。该领域以数十年来经典的遗传学和现代分子生物学为基础，应用先进的DNA定序和生物资讯技术，为预防保健、个人化营养、负责任的繁殖和疾病管理提供支援。这一领域使兽医、繁殖者和宠物饲主能够预测遗传疾病、优化健康护理方案并提高宠物的生活品质。技术的进步正在塑造精准兽医学的未来，同时也在维繫人类与伴侣动物之间的古老纽带。

宠物拥有率不断提高以及宠物的人性化

宠物饲养量的不断增长以及人类与宠物之间建立的深厚情感纽带是推动成长要素。宠物越来越被视为家庭成员，饲主投资先进的医疗保健、健康监测和预防性诊断。基因检测有助于饲主及早了解宠物的品种特征、行为倾向和遗传健康风险，从而实现主动护理。这种对动物由来已久的爱，在现代科学的推动下，持续推动对基于基因组的宠物解决方案的旺盛需求。

基因检测高成本

伴侣动物基因检测的高昂费用是限制市场发展的重要因素，尤其是在价格敏感地区。先进的DNA定序、生物资讯分析和实验室基础设施显着增加了检测成本。儘管人们对基因检测的认知不断提高，但这些高昂的费用仍然限制了许多宠物饲主，尤其是在新兴经济体的宠物主人，接受基因检测的意愿。此外，高昂的价格也阻碍了常规或重复检测，从而减缓了市场渗透率。在检测成本降低之前，费用壁垒很可能会继续阻碍市场的广泛扩张。

技术进步

基因组技术的快速发展为市场成长带来了巨大的机会。新一代定序、SNP基因型鉴定、人工智慧驱动的分析以及基于云端的生物资讯等领域的创新，在提高检测准确性的同时，也缩短了检测週期。这些技术进步也降低了营运成本，从而扩大了检测的覆盖范围。随着检测平台变得更有效率且便捷，企业可以将服务范围从品种鑑定扩展到疾病预测、营养规划和个人化护理等领域，从而在兽医和消费市场开闢新的收入来源。

监理和伦理问题

监管和伦理方面的挑战对市场构成潜在威胁。基因资料保护法、兽医法规和检测标准的区域差异使商业化进程变得复杂。关于资料所有权、育种中的基因歧视以及宠物DNA资讯滥用的伦理问题正导致审查力度加大。企业必须在不断变化的合规框架下保持透明度和信任度。未能应对这些挑战可能会延误核准，并影响企业的长期市场信誉。

新冠疫情的影响

新冠疫情对伴侣动物基因体学和DNA检测市场产生了复杂的影响。虽然供应链中断和检测实验室的临时关闭最初导致营运放缓，但封锁措施促使全球宠物领养数量激增。与宠物相处时间的增加使饲主更加关注健康，从而加速了对基因检测的兴趣。疫情后的復苏期，随着数位化订购、居家检体包以及与远端兽医服务的整合，市场需求进一步增强，并支撑了市场的韧性和长期成长。

预计在预测期内，犬种鑑定测试领域将占据最大的市场份额。

由于消费者需求强劲且认知度高，品种鑑定检测预计将在预测期内占据最大的市场份额。宠物饲主越来越希望了解品种组成，以便更好地理解宠物的动态特性、体型预测和潜在健康风险。该细分市场受益于面向消费者的直销试剂盒、简化的结果报告以及主要企业的强力行销。价格实惠即时实际价值，使得品种鑑定成为伴侣动物基因体学领域最广泛采用的切入点。

预计在预测期内，SNP基因分型领域将实现最高的复合年增长率。

由于其卓越的准确性和不断扩展的临床应用，SNP基因分型领域预计将在预测期内实现最高成长率。基于SNP的检测能够精确检测与遗传疾病、性状和药物反应相关的基因变异。兽医诊所和育种者越来越多地采用SNP进行高级诊断和预防保健，这推动了该领域的快速成长。随着成本的降低和数据解读能力的提高，SNP基因分型正成为精准兽医学的基础技术。

比最大的地区

由于宠物拥有率上升、都市化加快以及中产阶级人口不断壮大，亚太地区预计将在预测期内占据最大的市场份额。宠物健康意识提升、兽医基础设施的不断完善以及数位化宠物服务的蓬勃发展，都巩固了该地区的市场主导地位。中国、日本和澳洲等国家正迅速普及基因检测解决方案。伴侣动物消费的强劲成长以及先进诊断技术的普及，进一步巩固了该地区的主导地位。

复合年均成长率最高的地区

由于北美地区拥有先进的兽医基础设施、高额的宠物医疗保健支出以及对基因组技术的早期应用，预计该地区在预测期内将实现最高的复合年增长率。主要市场参与企业的强大影响力、面向消费者的检测套组的广泛普及以及宠物饲主较高的认知度，都在推动着这一增长。此外，持续的研究、创新以及将基因组学融入日常兽医实践的推动，也使北美成为成长最快的区域市场。

免费客製化服务

购买此报告的客户可享有以下免费自订选项之一：

  • 公司概况
    • 最多三家新增市场参与企业进行全面分析
    • 主要参与企业（最多3家公司）的SWOT分析
  • 区域细分
    • 根据客户要求，对主要国家进行市场估算和预测，并计算复合年增长率（註：可行性需确认）。
  • 竞争标竿分析
    • 从产品系列、地域覆盖范围和策略联盟等方面对主要参与企业进行基准分析

目录

第一章执行摘要

第二章 前言

  • 摘要
  • 相关利益者
  • 调查范围
  • 调查方法
  • 研究材料

第三章 市场趋势分析

  • 司机
  • 抑制因素
  • 机会
  • 威胁
  • 技术分析
  • 应用分析
  • 终端用户分析
  • 新兴市场
  • 新冠疫情的感染疾病

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球伴侣动物基因体学和DNA检测市场（按检测类型划分）

  • 品种鑑定测试
  • 基因健康风险检测
  • 疾病筛检和带原者检测
  • 性状和祖源检测
  • 健康管理和营养基因组检测

6. 全球伴侣动物基因体学和DNA检测市场（按动物类型划分）

  • 狗
  • 猫
  • 马
  • 其他动物类型

7. 全球伴侣动物基因体学和DNA检测市场（按分销管道划分）

  • 直接面向消费者（DTC）
  • 兽医通知的检查
  • 线上平台
  • 诊断实验室

8. 全球伴侣动物基因体学和DNA检测市场（依技术划分）

  • 基于PCR的检测
  • 下一代定序（NGS）
  • SNP基因型分析
  • 微阵列技术
  • 全基因组定序

9. 全球伴侣动物基因体学和DNA检测市场（按应用划分）

  • 疾病预测与预防
  • 个人化治疗方案
  • 育种管理
  • 行为和特征分析

第十章 全球伴侣动物基因体学和DNA检测市场（依最终用户划分）

  • 兽医医院和诊所
  • 宠物饲主
  • 研究所
  • 育种者和品种登记组织

11. 全球伴侣动物基因体学和DNA检测市场（按地区划分）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 亚太其他地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美国家
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十二章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 併购
  • 新产品发布
  • 业务拓展
  • 其他关键策略

第十三章：企业概况

  • Neogen Corporation
  • UC Davis Veterinary Genetics Laboratory
  • Zoetis Inc.
  • ZOOGEN
  • IDEXX Laboratories
  • Generatio GmbH
  • Thermo Fisher Scientific
  • VetGen LLC
  • Mars Petcare
  • Eurofins Scientific
  • Embark Veterinary
  • Antech Diagnostics
  • Basepaws
  • Animal Genetics Inc.
  • Orivet Genetic Pet Care
Product Code: SMRC32968

According to Stratistics MRC, the Global Companion Animal Genomics & DNA Testing Market is accounted for $864.55 million in 2025 and is expected to reach $1,510.75 million by 2032 growing at a CAGR of 8.3% during the forecast period. Companion Animal Genomics & DNA Testing refers to the scientific analysis of genetic material in pets such as dogs and cats to understand their breed composition, inherited traits, health risks, and ancestry. Built on decades of classical genetics and modern molecular biology, it applies advanced DNA sequencing and bioinformatics to support preventive healthcare, personalized nutrition, responsible breeding, and disease management. This field enables veterinarians, breeders, and pet owners to anticipate hereditary conditions, optimize wellness plans, and improve quality of life. As technology advances, it is shaping the future of precision veterinary care while preserving the time-honored bond between humans and their companion animals.

Market Dynamics:

Driver:

Rising Pet Ownership & Humanization of Pets

Rising pet ownership, coupled with the deepening emotional bond between humans and their companion animals, is a major growth driver for the market. Pets are increasingly viewed as family members, prompting owners to invest in advanced healthcare, wellness monitoring, and preventive diagnostics. Genetic testing helps owners understand breed traits, behavioral tendencies, and inherited health risks early, enabling proactive care. This long-standing love for animals, now reinforced by modern science, continues to fuel sustained demand for genomics-based pet solutions.

Restraint:

High Cost of Genetic Testing

The high cost associated with companion animal genetic testing acts as a notable market restraint, particularly in price-sensitive regions. Advanced DNA sequencing, bioinformatics analysis, and laboratory infrastructure significantly increase testing expenses. For many pet owners, especially in emerging economies, these costs limit adoption despite growing awareness. Additionally, premium pricing restricts routine or repeat testing, slowing market penetration. Until testing becomes more affordable, cost barriers will continue to challenge widespread market expansion.

Opportunity:

Advances in Technologies

Rapid advancements in genomic technologies present a strong opportunity for market growth. Innovations in next-generation sequencing, SNP genotyping, AI-driven analytics, and cloud-based bioinformatics are improving accuracy while reducing turnaround time. These technological improvements are also lowering operational costs, enabling broader accessibility. As testing platforms become more efficient and user-friendly, companies can expand offerings beyond breed identification to disease prediction, nutrition planning, and personalized care, opening new revenue streams across veterinary and consumer markets.

Threat:

Regulatory & Ethical Challenges

Regulatory and ethical challenges pose a potential threat to the market. Variations in genetic data protection laws, veterinary regulations, and testing standards across regions complicate commercialization. Ethical concerns surrounding data ownership, genetic discrimination in breeding, and misuse of pet DNA information further intensify scrutiny. Companies must navigate evolving compliance frameworks while maintaining transparency and trust. Failure to address these issues could slow approvals, and impact long-term market credibility.

Covid-19 Impact:

The COVID-19 pandemic had a mixed impact on the companion animal genomics and DNA testing market. While supply chain disruptions and temporary laboratory closures slowed operations initially, lockdowns triggered a surge in pet adoption globally. Increased time spent with pets heightened owner awareness of pet health and wellness, accelerating interest in genetic testing. Post-pandemic recovery has strengthened demand, with digital ordering, at-home sample kits, and tele-veterinary integration supporting market resilience and long-term growth.

The breed identification testing segment is expected to be the largest during the forecast period

The breed identification testing segment is expected to account for the largest market share during the forecast period, due to strong consumer demand and widespread awareness. Pet owners increasingly seek insights into breed composition to better understand behavior, size expectations, and potential health risks. This segment benefits from direct-to-consumer test kits, simplified reporting, and strong marketing by leading players. Its affordability and immediate, tangible value make breed identification the most widely adopted entry point into companion animal genomics.

The SNP genotyping segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the SNP genotyping segment is predicted to witness the highest growth rate, due to its superior accuracy and expanding clinical applications. SNP-based testing enables precise detection of genetic variations linked to inherited diseases, traits, and drug responses. Growing adoption by veterinary clinics and breeders for advanced diagnostics and preventive care supports rapid growth. As costs decline and data interpretation improves, SNP genotyping is emerging as the backbone technology for precision veterinary medicine.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, due to rising pet ownership, urbanization, and expanding middle-class populations. Increasing awareness of pet healthcare, coupled with growing veterinary infrastructure and digital pet services, supports market dominance. Countries such as China, Japan, and Australia are witnessing rapid adoption of genetic testing solutions. Strong growth in companion animal spending and improving access to advanced diagnostics underpin the region's leadership.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to advanced veterinary infrastructure, high pet healthcare expenditure, and early adoption of genomic technologies. Strong presence of key market players, widespread availability of direct-to-consumer testing kits, and high awareness among pet owners accelerate growth. Additionally, ongoing research, innovation, and integration of genomics into routine veterinary practice position North America as the fastest-growing regional market.

Key players in the market

Some of the key players in Companion Animal Genomics & DNA Testing Market include Neogen Corporation, UC Davis Veterinary Genetics Laboratory, Zoetis Inc., ZOOGEN, IDEXX Laboratories, Generatio GmbH, Thermo Fisher Scientific, VetGen LLC, Mars Petcare, Eurofins Scientific, Embark Veterinary, Antech Diagnostics, Basepaws, Animal Genetics Inc. and Orivet Genetic Pet Care.

Key Developments:

In October 2025, Mars Petcare and Big Idea Ventures have hand-picked three innovative startups for their 2025 Next Generation Pet Food Program, spotlighting sustainable biotech ingredients and circular feed solutions to transform pet nutrition and reduce environmental impact.

In March 2025, Mars, Incorporated has extended its partnership with the Washington Spirit, becoming the team's Official Petcare Partner, with its logo featured on jerseys and signage, community ticket donations, pet-friendly game nights, and collaborative fan and pet experiences.

Test Types Covered:

  • Breed Identification Testing
  • Genetic Health Risk Testing
  • Disease Screening & Carrier Testing
  • Trait & Ancestry Testing
  • Wellness & Nutrition Genomics

Animal Types Covered:

  • Dogs
  • Cats
  • Horses
  • Other Animal Types

Distribution Channels Covered:

  • Direct-to-Consumer (DTC)
  • Veterinary Referral Testing
  • Online Platforms
  • Diagnostic Laboratories

Technologies Covered:

  • PCR-based Testing
  • Next-Generation Sequencing (NGS)
  • SNP Genotyping
  • Microarray Technology
  • Whole Genome Sequencing

Applications Covered:

  • Disease Prediction & Prevention
  • Personalized Treatment Planning
  • Breeding Management
  • Behavioral & Trait Analysis

End Users Covered:

  • Veterinary Clinics & Hospitals
  • Pet Owners
  • Research Institutions
  • Breeders & Kennel Clubs

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Companion Animal Genomics & DNA Testing Market, By Test Type

  • 5.1 Introduction
  • 5.2 Breed Identification Testing
  • 5.3 Genetic Health Risk Testing
  • 5.4 Disease Screening & Carrier Testing
  • 5.5 Trait & Ancestry Testing
  • 5.6 Wellness & Nutrition Genomics

6 Global Companion Animal Genomics & DNA Testing Market, By Animal Type

  • 6.1 Introduction
  • 6.2 Dogs
  • 6.3 Cats
  • 6.4 Horses
  • 6.5 Other Animal Types

7 Global Companion Animal Genomics & DNA Testing Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Direct-to-Consumer (DTC)
  • 7.3 Veterinary Referral Testing
  • 7.4 Online Platforms
  • 7.5 Diagnostic Laboratories

8 Global Companion Animal Genomics & DNA Testing Market, By Technology

  • 8.1 Introduction
  • 8.2 PCR-based Testing
  • 8.3 Next-Generation Sequencing (NGS)
  • 8.4 SNP Genotyping
  • 8.5 Microarray Technology
  • 8.6 Whole Genome Sequencing

9 Global Companion Animal Genomics & DNA Testing Market, By Application

  • 9.1 Introduction
  • 9.2 Disease Prediction & Prevention
  • 9.3 Personalized Treatment Planning
  • 9.4 Breeding Management
  • 9.5 Behavioral & Trait Analysis

10 Global Companion Animal Genomics & DNA Testing Market, By End User

  • 10.1 Introduction
  • 10.2 Veterinary Clinics & Hospitals
  • 10.3 Pet Owners
  • 10.4 Research Institutions
  • 10.5 Breeders & Kennel Clubs

11 Global Companion Animal Genomics & DNA Testing Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Neogen Corporation
  • 13.2 UC Davis Veterinary Genetics Laboratory
  • 13.3 Zoetis Inc.
  • 13.4 ZOOGEN
  • 13.5 IDEXX Laboratories
  • 13.6 Generatio GmbH
  • 13.7 Thermo Fisher Scientific
  • 13.8 VetGen LLC
  • 13.9 Mars Petcare
  • 13.10 Eurofins Scientific
  • 13.11 Embark Veterinary
  • 13.12 Antech Diagnostics
  • 13.13 Basepaws
  • 13.14 Animal Genetics Inc.
  • 13.15 Orivet Genetic Pet Care

List of Tables

  • Table 1 Global Companion Animal Genomics & DNA Testing Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Companion Animal Genomics & DNA Testing Market Outlook, By Test Type (2024-2032) ($MN)
  • Table 3 Global Companion Animal Genomics & DNA Testing Market Outlook, By Breed Identification Testing (2024-2032) ($MN)
  • Table 4 Global Companion Animal Genomics & DNA Testing Market Outlook, By Genetic Health Risk Testing (2024-2032) ($MN)
  • Table 5 Global Companion Animal Genomics & DNA Testing Market Outlook, By Disease Screening & Carrier Testing (2024-2032) ($MN)
  • Table 6 Global Companion Animal Genomics & DNA Testing Market Outlook, By Trait & Ancestry Testing (2024-2032) ($MN)
  • Table 7 Global Companion Animal Genomics & DNA Testing Market Outlook, By Wellness & Nutrition Genomics (2024-2032) ($MN)
  • Table 8 Global Companion Animal Genomics & DNA Testing Market Outlook, By Animal Type (2024-2032) ($MN)
  • Table 9 Global Companion Animal Genomics & DNA Testing Market Outlook, By Dogs (2024-2032) ($MN)
  • Table 10 Global Companion Animal Genomics & DNA Testing Market Outlook, By Cats (2024-2032) ($MN)
  • Table 11 Global Companion Animal Genomics & DNA Testing Market Outlook, By Horses (2024-2032) ($MN)
  • Table 12 Global Companion Animal Genomics & DNA Testing Market Outlook, By Other Animal Types (2024-2032) ($MN)
  • Table 13 Global Companion Animal Genomics & DNA Testing Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 14 Global Companion Animal Genomics & DNA Testing Market Outlook, By Direct-to-Consumer (DTC) (2024-2032) ($MN)
  • Table 15 Global Companion Animal Genomics & DNA Testing Market Outlook, By Veterinary Referral Testing (2024-2032) ($MN)
  • Table 16 Global Companion Animal Genomics & DNA Testing Market Outlook, By Online Platforms (2024-2032) ($MN)
  • Table 17 Global Companion Animal Genomics & DNA Testing Market Outlook, By Diagnostic Laboratories (2024-2032) ($MN)
  • Table 18 Global Companion Animal Genomics & DNA Testing Market Outlook, By Technology (2024-2032) ($MN)
  • Table 19 Global Companion Animal Genomics & DNA Testing Market Outlook, By PCR-based Testing (2024-2032) ($MN)
  • Table 20 Global Companion Animal Genomics & DNA Testing Market Outlook, By Next-Generation Sequencing (NGS) (2024-2032) ($MN)
  • Table 21 Global Companion Animal Genomics & DNA Testing Market Outlook, By SNP Genotyping (2024-2032) ($MN)
  • Table 22 Global Companion Animal Genomics & DNA Testing Market Outlook, By Microarray Technology (2024-2032) ($MN)
  • Table 23 Global Companion Animal Genomics & DNA Testing Market Outlook, By Whole Genome Sequencing (2024-2032) ($MN)
  • Table 24 Global Companion Animal Genomics & DNA Testing Market Outlook, By Application (2024-2032) ($MN)
  • Table 25 Global Companion Animal Genomics & DNA Testing Market Outlook, By Disease Prediction & Prevention (2024-2032) ($MN)
  • Table 26 Global Companion Animal Genomics & DNA Testing Market Outlook, By Personalized Treatment Planning (2024-2032) ($MN)
  • Table 27 Global Companion Animal Genomics & DNA Testing Market Outlook, By Breeding Management (2024-2032) ($MN)
  • Table 28 Global Companion Animal Genomics & DNA Testing Market Outlook, By Behavioral & Trait Analysis (2024-2032) ($MN)
  • Table 29 Global Companion Animal Genomics & DNA Testing Market Outlook, By End User (2024-2032) ($MN)
  • Table 30 Global Companion Animal Genomics & DNA Testing Market Outlook, By Veterinary Clinics & Hospitals (2024-2032) ($MN)
  • Table 31 Global Companion Animal Genomics & DNA Testing Market Outlook, By Pet Owners (2024-2032) ($MN)
  • Table 32 Global Companion Animal Genomics & DNA Testing Market Outlook, By Research Institutions (2024-2032) ($MN)
  • Table 33 Global Companion Animal Genomics & DNA Testing Market Outlook, By Breeders & Kennel Clubs (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.